Role of multidrug-resistant bacteria in weaning from invasive mechanical ventilation.

Mortality in weaning Multidrug-resistant bacteria Prolonged weaning Weaning Weaning failure

Journal

Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633

Informations de publication

Date de publication:
05 Feb 2024
Historique:
received: 13 10 2023
accepted: 18 01 2024
medline: 6 2 2024
pubmed: 6 2 2024
entrez: 5 2 2024
Statut: epublish

Résumé

Although multidrug-resistant bacteria (MDR) are common in patients undergoing prolonged weaning, there is little data on their impact on weaning and patient outcomes. This is a retrospective analysis of consecutive patients who underwent prolonged weaning and were at a university weaning centre from January 2018 to December 2020. The influence of MDR colonisation and infection on weaning success (category 3a and 3b), successful prolonged weaning from invasive mechanical ventilation (IMV) with or without the need for non-invasive ventilation (NIV) compared with category 3c (weaning failure 3cI or death 3cII) was investigated. The pathogen groups considered were: multidrug-resistant gram-negative bacteria (MDRGN), methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus spp. (VRE). A total of 206 patients were studied, of whom 91 (44.2%) showed evidence of MDR bacteria (32% VRE, 1.5% MRSA and 16% MDRGN), with 25 patients also meeting the criteria for MDR infection. 70.9% of the 206 patients were successfully weaned from IMV, 8.7% died. In 72.2% of cases, nosocomial pneumonia and other infections were the main cause of death. Patients with evidence of MDR (infection and colonisation) had a higher incidence of weaning failure than those without evidence of MDR (48% vs. 34.8% vs. 21.7%). In multivariate analyses, MDR infection (OR 4.9, p = 0.004) was an independent risk factor for weaning failure, along with male sex (OR 2.3, p = 0.025), Charlson Comorbidity Index (OR 1.2, p = 0.027), pH (OR 2.7, p < 0.001) and duration of IMV before admission (OR 1.01, p < 0.001). In addition, MDR infection was the only independent risk factor for death (category 3cII), (OR 6.66, p = 0.007). Patients with MDR infection are significantly more likely to die during the weaning process. There is an urgent need to develop non-antibiotic approaches for the prevention and treatment of MDR infections as well as clinical research on antibiotic stewardship in prolonged weaning as well as in ICUs.

Sections du résumé

BACKGROUND BACKGROUND
Although multidrug-resistant bacteria (MDR) are common in patients undergoing prolonged weaning, there is little data on their impact on weaning and patient outcomes.
METHODS METHODS
This is a retrospective analysis of consecutive patients who underwent prolonged weaning and were at a university weaning centre from January 2018 to December 2020. The influence of MDR colonisation and infection on weaning success (category 3a and 3b), successful prolonged weaning from invasive mechanical ventilation (IMV) with or without the need for non-invasive ventilation (NIV) compared with category 3c (weaning failure 3cI or death 3cII) was investigated. The pathogen groups considered were: multidrug-resistant gram-negative bacteria (MDRGN), methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus spp. (VRE).
RESULTS RESULTS
A total of 206 patients were studied, of whom 91 (44.2%) showed evidence of MDR bacteria (32% VRE, 1.5% MRSA and 16% MDRGN), with 25 patients also meeting the criteria for MDR infection. 70.9% of the 206 patients were successfully weaned from IMV, 8.7% died. In 72.2% of cases, nosocomial pneumonia and other infections were the main cause of death. Patients with evidence of MDR (infection and colonisation) had a higher incidence of weaning failure than those without evidence of MDR (48% vs. 34.8% vs. 21.7%). In multivariate analyses, MDR infection (OR 4.9, p = 0.004) was an independent risk factor for weaning failure, along with male sex (OR 2.3, p = 0.025), Charlson Comorbidity Index (OR 1.2, p = 0.027), pH (OR 2.7, p < 0.001) and duration of IMV before admission (OR 1.01, p < 0.001). In addition, MDR infection was the only independent risk factor for death (category 3cII), (OR 6.66, p = 0.007).
CONCLUSION CONCLUSIONS
Patients with MDR infection are significantly more likely to die during the weaning process. There is an urgent need to develop non-antibiotic approaches for the prevention and treatment of MDR infections as well as clinical research on antibiotic stewardship in prolonged weaning as well as in ICUs.

Identifiants

pubmed: 38317197
doi: 10.1186/s12931-024-02694-5
pii: 10.1186/s12931-024-02694-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

69

Informations de copyright

© 2024. The Author(s).

Références

WeanNet Study G. [WeanNet: the network of weaning units of the DGP (Deutsche Gesellschaft fur pneumologie und Beatmungsmedizin) - results to epidemiology an outcome in patients with prolonged weaning]. Dtsch Med Wochenschr. 2016;141(18):e166–172.
Timsit JF, Bassetti M, Cremer O, Daikos G, de Waele J, Kallil A, Kipnis E, Kollef M, Laupland K, Paiva JA, Rodriguez-Bano J, Ruppe E, Salluh J, Taccone FS, Weiss E, Barbier F. Rationalizing antimicrobial therapy in the ICU: a narrative review. Intensive Care Med. 2019;45(2):172–89.
doi: 10.1007/s00134-019-05520-5 pubmed: 30659311
Tacconelli E, Gorska A, De Angelis G, Lammens C, Restuccia G, Schrenzel J, Huson DH, Carevic B, Preotescu L, Carmeli Y, Kazma M, Spanu T, Carrara E, Malhotra-Kumar S, Gladstone BP. Estimating the association between antibiotic exposure and colonization with extended-spectrum beta-lactamase-producing Gram-negative bacteria using machine learning methods: a multicentre, prospective cohort study. Clin Microbiol Infect. 2020;26(1):87–94.
doi: 10.1016/j.cmi.2019.05.013 pubmed: 31128285
Dantas LF, Dalmas B, Andrade RM, Hamacher S, Bozza FA. Predicting acquisition of carbapenem-resistant Gram-negative pathogens in intensive care units. J Hosp Infect. 2019;103(2):121–7.
doi: 10.1016/j.jhin.2019.04.013 pubmed: 31039381
Pop-Vicas A, Mitchell SL, Kandel R, Schreiber R, D’Agata EM. Multidrug-resistant gram-negative bacteria in a long-term care facility: prevalence and risk factors. J Am Geriatr Soc. 2008;56(7):1276–80.
doi: 10.1111/j.1532-5415.2008.01787.x pubmed: 18557965
Karanika S, Karantanos T, Arvanitis M, Grigoras C, Mylonakis E. Fecal colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae and risk factors among healthy individuals: a systematic review and metaanalysis. Clin Infect Dis. 2016;63(3):310–8.
doi: 10.1093/cid/ciw283 pubmed: 27143671
Pham T, Heunks L, Bellani G, Madotto F, Aragao I, Beduneau G, Goligher EC, Grasselli G, Laake JH, Mancebo J, Penuelas O, Piquilloud L, Pesenti A, Wunsch H, van Haren F, Brochard L, Laffey JG, Investigators WS. Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study. Lancet Respir Med. 2023;11(5):465–76.
doi: 10.1016/S2213-2600(22)00449-0 pubmed: 36693401
Vitacca M, Marino S, Comini L, Fezzardi L, Paneroni M. Bacterial colonization in COPD patients admitted to a Rehabilitation Respiratory Unit and impact on length of Stay: a real-life study. COPD. 2018;15(6):581–7.
doi: 10.1080/15412555.2019.1572731 pubmed: 30894078
Rollnik JD, Bertram M, Bucka C, Hartwich M, Jobges M, Ketter G, Leineweber B, Mertl-Rotzer M, Nowak DA, Platz T, Scheidtmann K, Thomas R, von Rosen F, Wallesch CW, Woldag H, Peschel P, Mehrholz J, Pohl M. Outcome of neurological early rehabilitation patients carrying multi-drug resistant bacteria: results from a German multi-center study. BMC Neurol. 2017;17(1):53.
doi: 10.1186/s12883-017-0833-2 pubmed: 28320357 pmcid: 5359920
Schonhofer B, Geiseler J, Dellweg D, Fuchs H, Moerer O, Weber-Carstens S, Westhoff M, Windisch W. Prolonged weaning: S2k Guideline published by the German respiratory society. Respiration 2020: 1–102.
Cerceo E, Deitelzweig SB, Sherman BM, Amin AN. Multidrug-resistant gram-negative bacterial infections in the hospital setting: overview, implications for clinical practice, and Emerging Treatment options. Microb Drug Resist. 2016;22(5):412–31.
doi: 10.1089/mdr.2015.0220 pubmed: 26866778
Boles JM, Bion J, Connors A, Herridge M, Marsh B, Melot C, Pearl R, Silverman H, Stanchina M, Vieillard-Baron A, Welte T. Weaning from mechanical ventilation. Eur Respir J. 2007;29(5):1033–56.
doi: 10.1183/09031936.00010206 pubmed: 17470624
Schonhofer B, Geiseler J, Dellweg D, Moerer O, Barchfeld T, Fuchs H, Karg O, Rosseau S, Sitter H, Weber-Carstens S, Westhoff M, Windisch W. S2k-Guideline prolonged Weaning. Pneumologie. 2015;69(10):595–607.
doi: 10.1055/s-0034-1392809 pubmed: 26444135
Jubran A, Grant BJ, Duffner LA, Collins EG, Lanuza DM, Hoffman LA, Tobin MJ. Effect of pressure support vs unassisted breathing through a tracheostomy collar on weaning duration in patients requiring prolonged mechanical ventilation: a randomized trial. JAMA. 2013;309(7):671–7.
doi: 10.1001/jama.2013.159 pubmed: 23340588 pmcid: 3711743
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, Ckd EPI. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.
Vardakas KZ, Rafailidis PI, Konstantelias AA, Falagas ME. Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: the study, the patient, the bug or the drug? J Infect. 2013;66(5):401–14.
doi: 10.1016/j.jinf.2012.10.028 pubmed: 23142195
Raman G, Avendano EE, Chan J, Merchant S, Puzniak L. Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2018;7:79.
doi: 10.1186/s13756-018-0370-9 pubmed: 29997889 pmcid: 6032536
Bassetti M, Righi E, Vena A, Graziano E, Russo A, Peghin M. Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug- resistant/extensively drug-resistant/pandrug-resistant bacteria. Curr Opin Crit Care. 2018;24(5):385–93.
doi: 10.1097/MCC.0000000000000534 pubmed: 30156569
Ceccarelli G, Alessandri F, Moretti S, Borsetti A, Maggiorella MT, Fabris S, Russo A, Ruberto F, De Meo D, Ciccozzi M, Mastroianni CM, Venditti M, Pugliese F, d’Ettorre G. Clinical Impact of Colonization with Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Admitted for Severe Trauma. Pathogens 2022: 11(11).
Grasselli G, Scaravilli V, Alagna L, Bombino M, De Falco S, Bandera A, Abbruzzese C, Patroniti N, Gori A, Pesenti A. Gastrointestinal colonization with multidrug-resistant Gram-negative bacteria during extracorporeal membrane oxygenation: effect on the risk of subsequent infections and impact on patient outcome. Ann Intensive Care. 2019;9(1):141.
doi: 10.1186/s13613-019-0615-7 pubmed: 31853672 pmcid: 6920277
Prado V, Hernandez-Tejero M, Mucke MM, Marco F, Gu W, Amoros A, Toapanta D, Reverter E, Pena-Ramirez C, Altenpeter L, Bassegoda O, Mezzano G, Aziz F, Juanola A, Rodriguez-Tajes S, Chamorro V, Lopez D, Reyes M, Hogardt M, Kempf VAJ, Ferstl PG, Zeuzem S, Martinez JA, Vila J, Arroyo V, Trebicka J, Fernandez J. Rectal colonization by resistant bacteria increases the risk of infection by the colonizing strain in critically ill patients with cirrhosis. J Hepatol. 2022;76(5):1079–89.
doi: 10.1016/j.jhep.2021.12.042 pubmed: 35074475
van Prehn J, Kaiser AM, van der Werff SD, van Mansfeld R, Vandenbroucke-Grauls C. Colonization sites in carriers of ESBL-producing Gram-negative bacteria. Antimicrob Resist Infect Control. 2018;7:52.
doi: 10.1186/s13756-018-0344-y pubmed: 29682287 pmcid: 5898019
Bickenbach J, Schoneis D, Marx G, Marx N, Lemmen S, Dreher M. Impact of multidrug-resistant bacteria on outcome in patients with prolonged weaning. BMC Pulm Med. 2018;18(1):141.
doi: 10.1186/s12890-018-0708-3 pubmed: 30126392 pmcid: 6102812
Magret M, Lisboa T, Martin-Loeches I, Manez R, Nauwynck M, Wrigge H, Cardellino S, Diaz E, Koulenti D, Rello J, Group E-VCS. Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study. Crit Care. 2011;15(1):R62.
doi: 10.1186/cc10036 pubmed: 21324159 pmcid: 3221995
Agbaht K, Diaz E, Munoz E, Lisboa T, Gomez F, Depuydt PO, Blot SI, Rello J. Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: a study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia. Crit Care Med. 2007;35(9):2064–70.
doi: 10.1097/01.CCM.0000277042.31524.66 pubmed: 17581489
Callejo-Torre F, Eiros Bouza JM, Olaechea Astigarraga P, Coma Del Corral MJ, Palomar Martinez M, Alvarez-Lerma F, Lopez-Pueyo MJ. Risk factors for methicillin-resistant Staphylococcus aureus colonisation or infection in intensive care units and their reliability for predicting MRSA on ICU admission. Infez Med. 2016;24(3):201–9.
pubmed: 27668900
Kollef MH, Micek ST. Antimicrobial stewardship programs: mandatory for all ICUs. Crit Care. 2012;16(6):179.
doi: 10.1186/cc11853 pubmed: 23176169 pmcid: 3672591
Kollef MH, Bassetti M, Francois B, Burnham J, Dimopoulos G, Garnacho-Montero J, Lipman J, Luyt CE, Nicolau DP, Postma MJ, Torres A, Welte T, Wunderink RG. The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship. Intensive Care Med 2017: 43(9): 1187–97.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.
doi: 10.1016/0021-9681(87)90171-8 pubmed: 3558716

Auteurs

Julia D Michels-Zetsche (JD)

Department of Pneumology and Critical Care, Thoraxklinik, University of Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Röntgenstrasse 1, D-69126, Heidelberg, Germany. Julia.Michels@med.uni-heidelberg.de.

Vicky Gassmann (V)

Department of Pneumology and Critical Care, Thoraxklinik, University of Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Röntgenstrasse 1, D-69126, Heidelberg, Germany.

Jasmin K Jasuja (JK)

Department for Infectious Diseases, University Hospital Heidelberg, Heidelberg, Germany.

Benjamin Neetz (B)

Department of Pneumology and Critical Care, Thoraxklinik, University of Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Röntgenstrasse 1, D-69126, Heidelberg, Germany.

Philipp Höger (P)

Department of Pneumology and Critical Care, Thoraxklinik, University of Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Röntgenstrasse 1, D-69126, Heidelberg, Germany.

Jan Meis (J)

Institute of Medical Biometry, University of Heidelberg, Heidelberg, Germany.

Simone Britsch (S)

Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, European Center for Angioscience (ECAS), University Medical Center Mannheim, German Center for Cardiovascular Research (DZHK), Partner Site, Heidelberg/Mannheim, Germany.

Urte Sommerwerck (U)

Department of Pneumology, Krankenhaus der Augustinerinnen Cologne, Cologne, Germany.

Sebastian Fähndrich (S)

Department of Pneumology, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.

Florian Bornitz (F)

Department of Pneumology and Internal Intensive Care Medicine, Asklepios Hospital Barmbek, Hamburg, Germany.

Michael M Müller (MM)

Department of Pneumology and Critical Care, Thoraxklinik, University of Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Röntgenstrasse 1, D-69126, Heidelberg, Germany.

Felix J F Herth (FJF)

Department of Pneumology and Critical Care, Thoraxklinik, University of Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Röntgenstrasse 1, D-69126, Heidelberg, Germany.

Franziska C Trudzinski (FC)

Department of Pneumology and Critical Care, Thoraxklinik, University of Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Röntgenstrasse 1, D-69126, Heidelberg, Germany.

Classifications MeSH